JARROD HERTZLER: Open Payments
NPI 1174194062 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$191 in 8 payments from 6 companies in 2025. Trend: 2023 $147 · 2024 $95 · 2025 $191
Food & beverage: $191
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $61 |
| Novartis Pharmaceuticals Corporation | 1 | $31 |
| Alexion Pharmaceuticals, Inc. | 1 | $30 |
| AKEBIA THERAPEUTICS INC | 1 | $27 |
| Calliditas Therapeutics US Inc. | 1 | $26 |
| Fresenius USA Marketing, Inc. | 1 | $14 |
Products named: Kerendia, Fabhalta, ULTOMIRIS, Vafseo, TARPEYO, VELPHORO.
Industry payments across TX — which companies pay providers there.
